The MYCB1 GmbH is a German pharmaceutical company based in Steinheim / Westfalen, specializing in the development, production, and marketing of prescription medical cannabis extracts. At our core is a commitment to meeting the needs of patients. We recognize the necessity of providing evidence-based results for the treatment of patients with cannabinoids.